Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases
LEUVEN, BELGIUM, March 23, 2021 /EINPresswire.com/ -- Augustine Therapeutics, a biotech spin-out company from VIB that focuses on the development of novel innovative therapies for rare peripheral neuropathies and neurogenerative disorders, has received …